Villers-lès-Nancy, June 9, 2016 - 18h30 (CET)
PRESS RELEASE
Annual Ordinary General Meeting on June 23, 2016
Notice
The shareholders of PHARMAGEST INTERACTIVE are invited to attend the Annual Ordinary General Meeting that will be held on Thursday, June 23, 2016 at 5.00 pm, at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.
The agenda and the draft resolutions were published in the BALO (Bulletin des Annonces Légales et Obligatoires) of May 16, 2016 (www.journal-officiel.gouv.fr).
The present notice of meeting was published in the BALO of June 6, 2016, in the Official Journal "Tablettes Lorraines" and on the company's website (www.pharmagest.com / Investor Relations).
Shareholders will be able to obtain the documents with regard to this Shareholders' Meeting on request from the company's registered office in VILLERS-LES-NANCY (54600).
About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in pharmacy information technology, with a 43.5% share of the market and over 800 employees. The strategy of the PHARMAGEST Group is based on a core business - innovating in information technology to improve healthcare - and on the development of two priority focuses: services and technologies for healthcare professionals, notably support for pharmacists in monitoring patient compliance; and technology for improving the efficacy of healthcare systems.
To roll out that strategy, the PHARMAGEST Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for laboratories, connected health devices and apps, and a sales financing marketplace.
These businesses are divided into 4 Divisions: the Solutions for Pharmacy Division - Europe, the Solutions for Sanitary and Medico-Social Establishments Division, the Solutions for e-Health Division, and the FinTech Division.
Listed on Euronext Paris(TM) - Compartment B
Indices: ENTERNEXT TECH 40, CAC ® SMALL and CAC ® All-Tradable by inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN: FR0012882389 - Reuters: PHA.PA - Bloomberg: PMGI FP
PHARMAGEST shares are eligible for France's Equity Savings Plan intended to finance
SMEs (PEA-PME)
For all the latest news, go to www.pharmagest.com
CONTACTS
Analyst and Investor Relations:
Chief Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@pharmagest.com
Press Relations:
FIN'EXTENSO - Isabelle APRILE
Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr
